Peter M. Chakoutis

Nessuna posizione attualmente

59 anni

Health Technology

Consumer Services

Profilo

Peter M.
Chakoutis served as the Chief Financial Officer at DUSA Pharmaceuticals, Inc. and as the Vice President-Finance at Harvard Apparatus Regenerative Technology, Inc. He also briefly served as the Chief Financial & Accounting Officer at Harvard Apparatus Regenerative Technology, Inc. Mr. Chakoutis holds an undergraduate degree from Norwich University and a graduate degree from Bentley Graduate School of Business.

Precedenti posizioni note di Peter M. Chakoutis

Società	Posizione	Fine
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Direttore Finanziario/CFO	29/10/2020
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Direttore Finanziario/CFO	17/01/2020
DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.	Direttore Finanziario/CFO	01/04/2005

Vedi nel dettaglio l'esperienza di Peter M. Chakoutis

Formazione di Peter M. Chakoutis

Norwich University	Undergraduate Degree
Bentley Graduate School of Business	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter M. Chakoutis

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Health Technology

Aziende private	1
DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.	Health Technology